Meanwhile, the hippocampal atrophy in patients in the medium-dose group was relatively small, but did not reach statistical significance.
← all excerpts
Stem cell and CRISPR/Cas9 gene editing technology in Alzheimer's disease therapy: from basic research to clinical innovation.
1
—
—